المؤلفون: Tramontana A.R., Tong S.Y.C., Lye D.C., Yahav D., Sud A., Robinson J.O., Nelson J., Archuleta S., Roberts M.A., Cass A., Paterson D.L., Foo H., Paul M., Guy S.D., Runnegar N., Andresen D.N., Anagnostou N.A., Johnson S.A., Chatfield M.D., Cheng A.C., Fowler V.G., Howden B.P., Meagher N., Price D.J., Van Hal S.J., O'Sullivan M.V.N., Davis J.S., Walls G.B., McBride S., Bak N., Ghosh N., Rogers B.A., Ralph A.P., Davies J., Ferguson P.E., Dotel R., McKew G.L., Gray T.J., Holmes N.E., Smith S., Warner M.S., Kalimuddin S., Young B.E.

مصطلحات الفهرس: vancomycin/iv [Intravenous Drug Administration], vancomycin/pv [Special Situation for Pharmacovigilance], daptomycin/iv [Intravenous Drug Administration], acute kidney failure/si [Side Effect], adult, aged, all cause mortality, article, clinical outcome, controlled study, diarrhea/si [Side Effect], drug efficacy, drug fever/si [Side Effect], drug monitoring, drug safety, female, follow up, general practitioner, hospitalization, human, hypertransaminasemia/si [Side Effect], major clinical study, male, methicillin resistant Staphylococcus aureus infection/dt [Drug Therapy], monotherapy, mortality rate, pilot study, priority journal, randomized controlled trial, rash/si [Side Effect], recurrent disease, therapy effect, thrombocytopenia/si [Side Effect], thrombophlebitis/si [Side Effect], treatment duration, treatment failure, cefazolin/ae [Adverse Drug Reaction], cefazolin/cb [Drug Combination], cefazolin/dt [Drug Therapy], cefazolin/iv [Intravenous Drug Administration], cefazolin/pv [Special Situation for Pharmacovigilance], cloxacillin/ae [Adverse Drug Reaction], cloxacillin/cb [Drug Combination], cloxacillin/dt [Drug Therapy], cloxacillin/iv [Intravenous Drug Administration], cloxacillin/pv [Special Situation for Pharmacovigilance], daptomycin/ae [Adverse Drug Reaction], daptomycin/cb [Drug Combination], daptomycin/dt [Drug Therapy], daptomycin/pv [Special Situation for Pharmacovigilance], flucloxacillin/ae [Adverse Drug Reaction], flucloxacillin/cb [Drug Combination], flucloxacillin/dt [Drug Therapy], flucloxacillin/iv [Intravenous Drug Administration], flucloxacillin/pv [Special Situation for Pharmacovigilance], vancomycin/ae [Adverse Drug Reaction], vancomycin/cb [Drug Combination], vancomycin/dt [Drug Therapy], Article

URL: JAMA - Journal of the American Medical Association
Click here for full text options
LibKey Link

المؤلفون: Tramontana A.R., Tong S.Y.C., Lye D.C., Yahav D., Sud A., Robinson J.O., Nelson J., Archuleta S., Roberts M.A., Cass A., Paterson D.L., Foo H., Paul M., Guy S.D., Runnegar N., Andresen D.N., Anagnostou N.A., Johnson S.A., Chatfield M.D., Cheng A.C., Fowler V.G., Howden B.P., Meagher N., Price D.J., Van Hal S.J., O'Sullivan M.V.N., Davis J.S., Walls G.B., McBride S., Bak N., Ghosh N., Rogers B.A., Ralph A.P., Davies J., Ferguson P.E., Dotel R., McKew G.L., Gray T.J., Holmes N.E., Smith S., Warner M.S., Kalimuddin S., Young B.E.

مصطلحات الفهرس: vancomycin/iv [Intravenous Drug Administration], vancomycin/pv [Special Situation for Pharmacovigilance], daptomycin/iv [Intravenous Drug Administration], acute kidney failure/si [Side Effect], adult, aged, all cause mortality, article, clinical outcome, controlled study, diarrhea/si [Side Effect], drug efficacy, drug fever/si [Side Effect], drug monitoring, drug safety, female, follow up, general practitioner, hospitalization, human, hypertransaminasemia/si [Side Effect], major clinical study, male, methicillin resistant Staphylococcus aureus infection/dt [Drug Therapy], monotherapy, mortality rate, pilot study, priority journal, randomized controlled trial, rash/si [Side Effect], recurrent disease, therapy effect, thrombocytopenia/si [Side Effect], thrombophlebitis/si [Side Effect], treatment duration, treatment failure, cefazolin/ae [Adverse Drug Reaction], cefazolin/cb [Drug Combination], cefazolin/dt [Drug Therapy], cefazolin/iv [Intravenous Drug Administration], cefazolin/pv [Special Situation for Pharmacovigilance], cloxacillin/ae [Adverse Drug Reaction], cloxacillin/cb [Drug Combination], cloxacillin/dt [Drug Therapy], cloxacillin/iv [Intravenous Drug Administration], cloxacillin/pv [Special Situation for Pharmacovigilance], daptomycin/ae [Adverse Drug Reaction], daptomycin/cb [Drug Combination], daptomycin/dt [Drug Therapy], daptomycin/pv [Special Situation for Pharmacovigilance], flucloxacillin/ae [Adverse Drug Reaction], flucloxacillin/cb [Drug Combination], flucloxacillin/dt [Drug Therapy], flucloxacillin/iv [Intravenous Drug Administration], flucloxacillin/pv [Special Situation for Pharmacovigilance], vancomycin/ae [Adverse Drug Reaction], vancomycin/cb [Drug Combination], vancomycin/dt [Drug Therapy], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29372
JAMA - Journal of the American Medical Association
LibKey Link

المؤلفون: De Courten M.P.J., De Courten B., Scragg R., Walker K., Kellow N., Teede H., Mousa A., Naderpoor N.

مصطلحات الفهرس: groups by age, human, hyperinsulinemic-euglycemic clamp technique, insulin blood level, insulin release, insulin resistance, insulin sensitivity, intravenous glucose tolerance test, lipid blood level, male, obesity, parallel design, randomized controlled trial, sex difference, sun exposure, thrombophlebitis/si [Side Effect], treatment duration, vitamin blood level, vitamin D deficiency/dt [Drug Therapy], vitamin intake, vitamin supplementation, 25 hydroxyvitamin D/ec [Endogenous Compound], colecalciferol/ae [Adverse Drug Reaction], colecalciferol/ct [Clinical Trial], colecalciferol/cm [Drug Comparison], colecalciferol/dt [Drug Therapy], colecalciferol/po [Oral Drug Administration], glucose/ec [Endogenous Compound], insulin/ec [Endogenous Compound], lipid/ec [Endogenous Compound], placebo, non insulin dependent diabetes mellitus, physical activity, adult, adult disease, article, body composition, body mass, bolus injection, cardiovascular risk, clinical article, controlled study, dietary intake, double blind procedure, drug withdrawal, dual energy X ray absorptiometry, fat free mass, fat mass, female, glucose blood level, glucose metabolism, gold standard, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/38843
American Journal of Clinical Nutrition
Click here for full text options
LibKey Link

المؤلفون: Shortt J., Ong T.C., Elhaddad A., Quach H., Pavlovsky C., Louw V.J., Shih L.-Y., Turkina A.G., Meillon L., Jin Y., Acharya S., Dalal D., Aurelio Salvino M., Lipton J.H., Hughes T.P., Munhoz E.

مصطلحات الفهرس: hypertransaminasemia/si [Side Effect], ischemic heart disease/si [Side Effect], leukopenia/si [Side Effect], liver toxicity/si [Side Effect], lung edema/si [Side Effect], lymphocytopenia/si [Side Effect], major clinical study, male, multicenter study (topic), nausea/si [Side Effect], neutropenia/si [Side Effect], overall survival, pancreatitis/si [Side Effect], peripheral edema/si [Side Effect], peripheral occlusive artery disease/si [Side Effect], phase 3 clinical trial (topic), pleura effusion/si [Side Effect], priority journal, progression free survival, pruritus/si [Side Effect], QT prolongation/si [Side Effect], rash/si [Side Effect], retina vein occlusion/si [Side Effect], side effect/si [Side Effect], thrombocytopenia/si [Side Effect], thrombophlebitis/si [Side Effect], upper respiratory tract infection/si [Side Effect], alanine aminotransferase/ec [Endogenous Compound], BCR ABL protein/ec [Endogenous Compound], bilirubin/ec [Endogenous Compound], glucose/ec [Endogenous Compound], magnesium/ec [Endogenous Compound], nilotinib/ae [Adverse Drug Reaction], nilotinib/ct [Clinical Trial], nilotinib/dt [Drug Therapy], phosphate/ec [Endogenous Compound], sodium/ec [Endogenous Compound], triacylglycerol lipase/ec [Endogenous Compound], unclassified drug, BCR ABL1 protein/ec [Endogenous Compound], drug efficacy, adult, aged, alopecia/si [Side Effect], anemia/si [Side Effect], artery occlusion/si [Side Effect], article, bleeding/si [Side Effect], brain ischemia/si [Side Effect], cardiovascular disease/si [Side Effect], central nervous system disease/si [Side Effect], central nervous system hemorrhage/si [Side Effect], chronic myeloid leukemia/dt [Drug Therapy], constipation/si [Side Effect], coronary artery disease/si [Side Effect], deep vein thrombosis/si [Side Effect], drug dose escalation, drug dose reduction, drug safety, drug treatment failure, drug withdrawal, fatigue/si [Side Effect], female, follow up, gastrointestinal hemorrhage/si [Side Effect], headache/si [Side Effect], heart muscle ischemia/si [Side Effect], human, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/38341
British Journal of Haematology
Click here for full text options
LibKey Link

المؤلفون: De Courten M.P.J., De Courten B., Scragg R., Walker K., Kellow N., Teede H., Mousa A., Naderpoor N.

مصطلحات الفهرس: groups by age, human, hyperinsulinemic-euglycemic clamp technique, insulin blood level, insulin release, insulin resistance, insulin sensitivity, intravenous glucose tolerance test, lipid blood level, male, obesity, parallel design, randomized controlled trial, sex difference, sun exposure, thrombophlebitis/si [Side Effect], treatment duration, vitamin blood level, vitamin D deficiency/dt [Drug Therapy], vitamin intake, vitamin supplementation, 25 hydroxyvitamin D/ec [Endogenous Compound], colecalciferol/ae [Adverse Drug Reaction], colecalciferol/ct [Clinical Trial], colecalciferol/cm [Drug Comparison], colecalciferol/dt [Drug Therapy], colecalciferol/po [Oral Drug Administration], glucose/ec [Endogenous Compound], insulin/ec [Endogenous Compound], lipid/ec [Endogenous Compound], placebo, non insulin dependent diabetes mellitus, physical activity, adult, adult disease, article, body composition, body mass, bolus injection, cardiovascular risk, clinical article, controlled study, dietary intake, double blind procedure, drug withdrawal, dual energy X ray absorptiometry, fat free mass, fat mass, female, glucose blood level, glucose metabolism, gold standard, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/38843
American Journal of Clinical Nutrition
Click here for full text options
LibKey Link

المؤلفون: Shortt J., Ong T.C., Elhaddad A., Quach H., Pavlovsky C., Louw V.J., Shih L.-Y., Turkina A.G., Meillon L., Jin Y., Acharya S., Dalal D., Aurelio Salvino M., Lipton J.H., Hughes T.P., Munhoz E.

مصطلحات الفهرس: hypertransaminasemia/si [Side Effect], ischemic heart disease/si [Side Effect], leukopenia/si [Side Effect], liver toxicity/si [Side Effect], lung edema/si [Side Effect], lymphocytopenia/si [Side Effect], major clinical study, male, multicenter study (topic), nausea/si [Side Effect], neutropenia/si [Side Effect], overall survival, pancreatitis/si [Side Effect], peripheral edema/si [Side Effect], peripheral occlusive artery disease/si [Side Effect], phase 3 clinical trial (topic), pleura effusion/si [Side Effect], priority journal, progression free survival, pruritus/si [Side Effect], QT prolongation/si [Side Effect], rash/si [Side Effect], retina vein occlusion/si [Side Effect], side effect/si [Side Effect], thrombocytopenia/si [Side Effect], thrombophlebitis/si [Side Effect], upper respiratory tract infection/si [Side Effect], alanine aminotransferase/ec [Endogenous Compound], BCR ABL protein/ec [Endogenous Compound], bilirubin/ec [Endogenous Compound], glucose/ec [Endogenous Compound], magnesium/ec [Endogenous Compound], nilotinib/ae [Adverse Drug Reaction], nilotinib/ct [Clinical Trial], nilotinib/dt [Drug Therapy], phosphate/ec [Endogenous Compound], sodium/ec [Endogenous Compound], triacylglycerol lipase/ec [Endogenous Compound], unclassified drug, BCR ABL1 protein/ec [Endogenous Compound], drug efficacy, adult, aged, alopecia/si [Side Effect], anemia/si [Side Effect], artery occlusion/si [Side Effect], article, bleeding/si [Side Effect], brain ischemia/si [Side Effect], cardiovascular disease/si [Side Effect], central nervous system disease/si [Side Effect], central nervous system hemorrhage/si [Side Effect], chronic myeloid leukemia/dt [Drug Therapy], constipation/si [Side Effect], coronary artery disease/si [Side Effect], deep vein thrombosis/si [Side Effect], drug dose escalation, drug dose reduction, drug safety, drug treatment failure, drug withdrawal, fatigue/si [Side Effect], female, follow up, gastrointestinal hemorrhage/si [Side Effect], headache/si [Side Effect], heart muscle ischemia/si [Side Effect], human, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/38341
British Journal of Haematology
Click here for full text options
LibKey Link

المؤلفون: O'Connor D.W., Hall K.A., Keks N.A.

مصطلحات الفهرس: hospital patient, human, male, Mini Mental State Examination, nursing home, peripheral edema/si [Side Effect], physical examination, randomized controlled trial, rating scale, rebound, testosterone blood level, thrombophlebitis/si [Side Effect], treatment outcome, benzodiazepine/dt [Drug Therapy], estradiol/ae [Adverse Drug Reaction], estradiol/ct [Clinical Trial], estradiol/cr [Drug Concentration], estradiol/dt [Drug Therapy], estradiol/td [Transdermal Drug Administration], estrogen/ae [Adverse Drug Reaction], estrogen/ct [Clinical Trial], estrogen/cr [Drug Concentration], estrogen/dt [Drug Therapy], estrogen/td [Transdermal Drug Administration], psychotropic agent/dt [Drug Therapy], testosterone/ec [Endogenous Compound], dementia, adult, aged, aggression, article, behavior disorder/dt [Drug Therapy], clinical article, clinical trial, controlled clinical trial, controlled study, disease course, drug efficacy, drug tolerability, estrogen blood level, geriatric patient, gynecomastia/si [Side Effect], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/32253
Click here for full text options
LibKey Link

المؤلفون: O'Connor D.W., Hall K.A., Keks N.A.

مصطلحات الفهرس: hospital patient, human, male, Mini Mental State Examination, nursing home, peripheral edema/si [Side Effect], physical examination, randomized controlled trial, rating scale, rebound, testosterone blood level, thrombophlebitis/si [Side Effect], treatment outcome, benzodiazepine/dt [Drug Therapy], estradiol/ae [Adverse Drug Reaction], estradiol/ct [Clinical Trial], estradiol/cr [Drug Concentration], estradiol/dt [Drug Therapy], estradiol/td [Transdermal Drug Administration], estrogen/ae [Adverse Drug Reaction], estrogen/ct [Clinical Trial], estrogen/cr [Drug Concentration], estrogen/dt [Drug Therapy], estrogen/td [Transdermal Drug Administration], psychotropic agent/dt [Drug Therapy], testosterone/ec [Endogenous Compound], dementia, adult, aged, aggression, article, behavior disorder/dt [Drug Therapy], clinical article, clinical trial, controlled clinical trial, controlled study, disease course, drug efficacy, drug tolerability, estrogen blood level, geriatric patient, gynecomastia/si [Side Effect], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/32253
LibKey Link